These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 17714837)

  • 1. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
    von Kries R; Siedler A; Schmitt HJ; Reinert RR
    Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
    Albrich WC; Baughman W; Schmotzer B; Farley MM
    Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
    Li ST; Tancredi DJ
    Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
    Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
    Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J; Benes C; Kriz P
    Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
    Silfverdal SA; Berg S; Hemlin C; Jokinen I
    Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.
    Shibl A; Memish Z; Pelton S
    Int J Antimicrob Agents; 2009 May; 33(5):410.e1-9. PubMed ID: 18976887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
    Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
    Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
    Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
    Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.